Genelux Statistics
NASDAQ: GNLXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.50-0.02 (-0.79%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Genelux by the numbers
Genelux has a market capitalization of $113.1 million based on 45.25M shares outstanding. With trailing EPS of $-0.86, Genelux is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.4% below its 50-day average and 11.0% below its 200-day average.
Average daily trading volume is 276.16K shares, or about $690,400 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GNLX valuation vs. peer median
| Metric | GNLX | Peer median | Difference |
|---|---|---|---|
| Market cap | $113.11M | $114.78M | -1% |
| Avg. volume | 276.16K | 676.32K | -59% |
Peer median across 8 companies: INO, PMVP, UNCY, RANI, QUCY, COYA, FHTX, VTVT.
Valuation
- Market cap
- $113.11M
- EPS (TTM)
- $-0.86
- Shares outstanding
- 45.25M
Price and trading
- Previous close
- 2.52
- Open
- 2.50
- Day range
- 2.42 – 2.53
- 52-week range
- 2.29 – 8.54
- 52-week change
- -47.37%
- Beta
- —
- Volume
- 259.08K
- Average volume
- 276.16K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 113.11M
- Forward Pe
- -3.33
- Eps
- -0.86
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.54
- Week52 Low
- 2.29
- Avg Volume
- 276.16K
- Shares Outstanding
- 45.25M
- Ma50
- 2.61
- Ma200
- 2.81
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -70.71%
- Pct From52w Low
- 9.17%